As of 2024-07-27, the EV/EBITDA ratio of Insmed Inc (INSM) is -19.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSM's latest enterprise value is 12,752.54 mil USD. INSM's TTM EBITDA according to its financial statements is -656.91 mil USD. Dividing these 2 quantities gives us the above INSM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 20.4x | 18.0x |
| Forward P/E multiples | 17.6x - 24.1x | 21.4x |
| Fair Price | (74.55) - (85.75) | (82.91) |
| Upside | -200.0% - -215.0% | -211.2% |
| Date | EV/EBITDA |
| 2024-07-26 | -19.41 |
| 2024-07-25 | -19.40 |
| 2024-07-24 | -19.39 |
| 2024-07-23 | -19.77 |
| 2024-07-22 | -19.84 |
| 2024-07-19 | -19.77 |
| 2024-07-18 | -19.54 |
| 2024-07-17 | -19.66 |
| 2024-07-16 | -20.27 |
| 2024-07-15 | -20.14 |
| 2024-07-12 | -19.95 |
| 2024-07-11 | -20.03 |
| 2024-07-10 | -19.06 |
| 2024-07-09 | -18.35 |
| 2024-07-08 | -18.30 |
| 2024-07-05 | -18.29 |
| 2024-07-03 | -16.30 |
| 2024-07-02 | -16.92 |
| 2024-07-01 | -17.38 |
| 2024-06-28 | -17.54 |
| 2024-06-27 | -17.53 |
| 2024-06-26 | -18.03 |
| 2024-06-25 | -18.21 |
| 2024-06-24 | -17.90 |
| 2024-06-21 | -17.79 |
| 2024-06-20 | -16.97 |
| 2024-06-18 | -17.19 |
| 2024-06-17 | -16.97 |
| 2024-06-14 | -16.78 |
| 2024-06-13 | -16.21 |
| 2024-06-12 | -16.21 |
| 2024-06-11 | -16.27 |
| 2024-06-10 | -15.78 |
| 2024-06-07 | -15.02 |
| 2024-06-06 | -15.10 |
| 2024-06-05 | -15.26 |
| 2024-06-04 | -15.06 |
| 2024-06-03 | -14.80 |
| 2024-05-31 | -14.57 |
| 2024-05-30 | -15.05 |
| 2024-05-29 | -14.20 |
| 2024-05-28 | -12.84 |
| 2024-05-24 | -6.37 |
| 2024-05-23 | -6.77 |
| 2024-05-22 | -6.91 |
| 2024-05-21 | -7.00 |
| 2024-05-20 | -7.25 |
| 2024-05-17 | -7.06 |
| 2024-05-16 | -7.14 |
| 2024-05-15 | -7.10 |